
Aurinia Pharmaceuticals Inc (AUPH) gets rating Resumed from H.C. Wainwright
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Aurinia Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Keenan Greg unloaded Company’s shares for reported $68350.0 on